Artificial Intelligence for Drug Discovery Market (By Drug Type: Small Molecule, Large Molecule; By Technology: Deep Learning, Machine Learning; By Application: Metabolic Disease, Cardiovascular Diseases, Oncology, Neurodegenerative Diseases, Others; By End use: Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Artificial Intelligence for Drug Discovery
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Artificial Intelligence for Drug Discovery Market By Drug Type
     1.2.2.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Drug Type (2015-2026)
     1.2.2.2. Global Artificial Intelligence for Drug Discovery Market Revenue Share By Drug Type in 2018
     1.2.2.3. Small Molecule
     1.2.2.4. Large Molecule
   1.2.3. Artificial Intelligence for Drug Discovery Market By Technology
     1.2.3.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Technology (2015-2026)
     1.2.3.2. Deep Learning
     1.2.3.3. Machine Learning
   1.2.4. Artificial Intelligence for Drug Discovery Market By Application
     1.2.4.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Application (2015-2026)
     1.2.4.2. Metabolic Disease
     1.2.4.3. Cardiovascular Diseases
     1.2.4.4. Oncology
     1.2.4.5. Neurodegenerative Diseases
     1.2.4.6. Others
   1.2.5. Artificial Intelligence for Drug Discovery Market By End use
     1.2.5.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By End User (2015-2026)
     1.2.5.2. Pharmaceutical & Biotechnological Companies
     1.2.5.3. Academic & Research Institutes
     1.2.5.4. Others
   1.2.6. Artificial Intelligence for Drug Discovery Market By Geography
     1.2.6.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.6.2. North America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
     1.2.6.3. Europe Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
     1.2.6.4. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
     1.2.6.5. Latin America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
     1.2.6.6. Middle East and Africa (MEA)Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018

CHAPTER 4. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY DRUG TYPE
4.1. Global Artificial Intelligence for Drug Discovery Revenue By Drug Type
4.2. Small Molecule
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Large Molecule
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY TECHNOLOGY
5.1. Global Artificial Intelligence for Drug Discovery Revenue By Technology
5.2. Deep Learning
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Machine Learning
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY APPLICATION
6.1. Global Artificial Intelligence for Drug Discovery Revenue By Application
6.2. Metabolic Disease
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Cardiovascular Diseases
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Oncology
   6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Neurodegenerative Diseases
   6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Others
   6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET By END USE
7.1. Global Artificial Intelligence for Drug Discovery Revenue By End Use
7.2. Pharmaceutical & Biotechnological Companies
   7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Academic & Research Institutes
   7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Others
   7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
8.1. North America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
   8.3.1. U.S. Artificial Intelligence for Drug Discovery Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Canada
   8.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
9.1. Europe Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
   9.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Germany
   9.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. France
   9.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Spain
   9.6.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.6.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. Rest of Europe
   9.7.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.7.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
10.1. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
   10.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Japan
   10.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. India
   10.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.6. Australia
   10.6.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.6.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.7. South Korea
   10.7.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.7.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
   10.8.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   10.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.8.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
11.1. Latin America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
   11.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   11.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. Mexico
   11.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   11.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
   11.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   11.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
12.1. Middle East & Africa Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
   12.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   12.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.4. South Africa
   12.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   12.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
   12.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
   12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   12.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Atomwise, Inc.
   13.1.1. Company Snapshot
   13.1.2. Overview
   13.1.3. Financial Overview
   13.1.4. Type Portfolio
   13.1.5. Key Developments
   13.1.6. Strategies
13.2. Insilico Medicine
   13.2.1. Company Snapshot
   13.2.2. Overview
   13.2.3. Financial Overview
   13.2.4. Type Portfolio
   13.2.5. Key Developments
   13.2.6. Strategies
13.3. BIOAGE
   13.3.1. Company Snapshot
   13.3.2. Overview
   13.3.3. Financial Overview
   13.3.4. Type Portfolio
   13.3.5. Key Developments
   13.3.6. Strategies
13.4. Numerate
   13.4.1. Company Snapshot
   13.4.2. Overview
   13.4.3. Financial Overview
   13.4.4. Type Portfolio
   13.4.5. Key Developments
   13.4.6. Strategies
13.5. NuMedii, Inc.
   13.5.1. Company Snapshot
   13.5.2. Overview
   13.5.3. Financial Overview
   13.5.4. Type Portfolio
   13.5.5. Key Developments
   13.5.6. Strategies
13.6. Envisagenics
   13.6.1. Company Snapshot
   13.6.2. Overview
   13.6.3. Financial Overview
   13.6.4. Type Portfolio
   13.6.5. Key Developments
   13.6.6. Strategies
13.7. Cloud Pharmaceuticals, Inc.
   13.7.1. Company Snapshot
   13.7.2. Overview
   13.7.3. Financial Overview
   13.7.4. Type Portfolio
   13.7.5. Key Developments
   13.7.6. Strategies
13.8. BenevolentAI
   13.8.1. Company Snapshot
   13.8.2. Overview
   13.8.3. Financial Overview
   13.8.4. Type Portfolio
   13.8.5. Key Developments
   13.8.6. Strategies
13.9. twoXAR
   13.9.1. Company Snapshot
   13.9.2. Overview
   13.9.3. Financial Overview
   13.9.4. Type Portfolio
   13.9.5. Key Developments
   13.9.6. Strategies
13.10. Exscientia
   13.10.1. Company Snapshot
   13.10.2. Overview
   13.10.3. Financial Overview
   13.10.4. Type Portfolio
   13.10.5. Key Developments
   13.10.6. Strategies
13.11. Others
   13.11.1. Company Snapshot
   13.11.2. Overview
   13.11.3. Financial Overview
   13.11.4. Type Portfolio
   13.11.5. Key Developments
   13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
   14.1.1. Initial Data Search
   14.1.2. Secondary Research
   14.1.3. Primary Research
14.2. Assumptions and Scope